Doctors urge Mansukh Mandaviya, NMC to reconsider 3 year internship rule for FMGs

Pointing out the plights of foreign medical graduates (FMGs), especially delay in achieving their academic goals, the Foreign Medical Students’ Wing of the All India Medical Students’ Association (AIMSA) has urged the Union Health Minister Mansukh Mandaviya and the National Medical Commission (NMC) to reconsider and revise the 3-year internship and clerkship rule.

Referring to the NMC notices dated 22.11.2023 and 07.12.2023 directing the FMGs to undergo additional years of training to compensate for practical training lost due to COVID-19 and the war in Ukraine, the association highlighted that these added years present a significant setback in the academic journey of the affected students.

For more information, click on the link below:

Powered by WPeMatico

6 people died in explosion at pharma plant premises

The toll in the explosion within a chemical reactor at a facility of pharmaceutical firm in the Telangana’s Sangareddy district climbed to six, as officially confirmed by the police on Thursday.

Four individuals lost their lives, and sixteen others sustained injuries in the explosion that took place at the SB Organics Ltd’s factory, situated in Chandapur village of Hathnoora mandal of the district on Wednesday.

For more information, click on the link below:

Powered by WPeMatico

Seat matrix for DM Pediatric Pulmonology at AIIMS Jodhpur revised, Details

New Delhi- Through a notice, the examination section of All India Institute of Medical Sciences (AIIMS) has informed of a division of 2 seats of DM Pediatric Pulmonology speciality at AIIMS Jodhpur for INI SS July 2024.

As per the revised seat matrix, now there is 1 seat each in the general and sponsored categories in DM Pediatric Pulmonology. Earlier there were 2 seats in the general category.

SEAT MATRIX

S.NO

SUBJECT

INSTITUTE

EARLIER SEATS

REVISED SEATS

1

DM-PAEDIATRIC PULMONOLOGY

AIIMS JODHPUR

General

SPONSORED

Foreign National

General

SPONSORED

Foreign National

2

0

0

1

1

0

Medical Dialogues had earlier reported that as per the revised seat matrix, a total of 3 seats have been added in 3 DM courses and 01 seat in MD (Hospital Administration). Meanwhile, 2 seats in DM Nephrology have been removed from AIIMS Bhubaneswar.

INI-SS for July 2024 session is planned to be held in 16 cities in India such as Ahmedabad, Puducherry, Bhopal, Bhopal. It is been conducted for the admission to DM, MCh and MD (Hospital Administration) courses in AIIMS, PGIMER, NIMHANS, SCTIMST and JIPMER for the July 2024 session.

APPLICATION FEE

All Applicants

Rs.4000.00 + Transaction Charges as applicable (Non-Refundable)

PWBD

Exempted

AGE RELAXATION

1 For AIIMS New Delhi & Other AIIMS the Upper Age limit is 35 years as on 1st July, 2024, i.e. Born on or after 01.07.1989.

2 For PGIMER, Chandigarh the Upper Age limit is 45 years as on 1st July, 2024, i.e. Born on or after 01.07.1979.

3 For NIMHANS, Bengaluru the Upper Age limit is 37 years as on 1st July, 2024, i.e. Born on or after 01.07.1987.

4 For SCTIMST, Thiruvananthapuram the Upper Age limit is 40 years as on 1st July, 2024, i.e. Born on or after 01.07.1984.

5 For JIPMER, Puducherry there is No Upper Age Limit.

Age Relaxation applicable at all INIs-

a The Upper age limit is relaxable for OBC Candidates by a maximum of 3 years, for SC/ST candidates by a maximum of 5 years and for Ex-Serviceman and Commissioned Officers including ECO, SSCO who have rendered or released on satisfactory assignments with age relaxation by a maximum of 5 years.

b The upper age limit is not applicable to sponsored candidates.

c The persons with benchmark disabilities shall be given an upper age relaxation of five years for admission to DM/M.Ch. for PWD candidates as per the Rights of Persons with Disability Act, 2016.

d At NIMHANS Bengaluru, the Upper age limit is 37 years as on 1st July, 2024, i.e. Born on or after 01.07.1987, for all Category Candidates i.e. for UR, OBC, EWS, SC, ST & PWBD.

To view the notice, click the link below

Powered by WPeMatico

Health Bulletin 05/ April/ 2024

Here are the top health news for the day:

Blast at pharma plant premises

The toll in the explosion within a chemical reactor at a facility of pharmaceutical firm in the Telangana’s Sangareddy district climbed to six, as officially confirmed by the police on Thursday.

Four individuals lost their lives, and sixteen others sustained injuries in the explosion that took place at the SB Organics Ltd’s factory, situated in Chandapur village of Hathnoora mandal of the district on Wednesday.

For more information, click on the link below:

Doctors urge Health Minister, NMC to reconsider 3-year internship rule for FMGs

Pointing out the plights of foreign medical graduates (FMGs), especially delay in achieving their academic goals, the Foreign Medical Students’ Wing of the All India Medical Students’ Association (AIMSA) has urged the Union Health Minister Mansukh Mandaviya and the National Medical Commission (NMC) to reconsider and revise the 3-year internship and clerkship rule.

Referring to the NMC notices dated 22.11.2023 and 07.12.2023 directing the FMGs to undergo additional years of training to compensate for practical training lost due to COVID-19 and the war in Ukraine, the association highlighted that these added years present a significant setback in the academic journey of the affected students.

For more information, click on the link below:


MoHFW removes Glyceryl Trinitrate, Isosorbide Dinitrate from Schedule P1

The Ministry of Health and Family Welfare has amended the Drugs Rules, 1945 by removing Glyceryl Trinitrate and Isosorbide Dinitrate from Schedule P1 which contains regulations regarding the retail package size of various drugs.

The amended rules furthermore stated that, for drugs not covered by Schedule P-1, the pack sizes of tablets and capsules should be as follows: if the number of tablets (coated or uncoated) or capsules (hard or soft gelatine) is less than 10, the packing should be made according to the integral number; if the number is more than 10, the pack sizes of tablets and capsules should contain multiples of five or seven.

For more information, click on the link below:

Experts warn of H5N1 Bird flu outbreak: Risk 100 times greater than Covid pandemic

As the world grapples with the ongoing Covid-19 pandemic, experts have sounded a stark warning about the looming threat of another global health crisis: bird flu. According to a report by the Daily Mail, concerns are mounting over the potential rapid spread of the H5N1 strain of bird flu, which experts fear could be “100 times worse than the Covid pandemic.”
During a recent briefing, experts discussed the alarming characteristics of the H5N1 virus, highlighting its ability to infect a wide range of mammals, including humans. Dr. Suresh Kuchipudi, a prominent bird flu researcher, cautioned that the world is dangerously close to witnessing a pandemic caused by H5N1. He stressed the urgent need for preparedness, emphasizing that the virus is already circulating globally and infecting mammals.

Powered by WPeMatico

Boy with fractured arm allegedly turned away by 2 Delhi Hospitals, Health Minister orders probe

New Delhi: Two state-run hospitals in  East Delhi — Dr Hedgewar Aarogya Sansthan and Chacha Nehru Bal Chikitsalaya have come under the public spotlight for allegedly denying treatment to an eight-year-old boy with a broken left arm for reasons like shortage of medical supplies and unavailability of an orthopaedic doctor. 

TOI covering the story highlighted the case of the boy who was turned away by these hospitals which prompted his father, a security guard with a monthly salary of Rs 15,000 to seek medical treatment for his son from a private medical facility and cough up an amount of Rs 13,000, including a doctor’s consultation fee.

While one hospital stated that they did not have any cotton available, the other hospital stated that there was no orthopaedic doctor available for treatment after the consultation period.

Also read- 3 Resident Doctors Of Gynaecology Dept Suspended After Woman Delivers Outside Jaipur Hospital

Expressing concern about the incident, Health Minister Saurabh Bharadwaj wrote a letter to Lieutenant Governor VK Saxena demanding strict action against officials responsible for the non-availability of medicines and consumables at Delhi govt health facilities. 

Moreover, he also called for a comprehensive investigation to be carried out within a specific timeframe to hold them responsible for distorting facts and misleading the government.

The incident took place on April 1, however, it was brought to attention by social activist Ashok Agarwal on the social networking site X, previously known as Twitter. The boy, a Class II student of an MCD primary school in Karkardooma severely fractured his left arm while playing in the school and was rushed to Dr Hedgewar Aarogya Sansthan’s emergency ward by the school administration.

The doctor on duty there referred the boy to another healthcare centre for slab application and asked him to buy cotton since it was unavailable at the hospital.  On his emergency card, the doctor wrote, “Cotton was not available, patient advised to buy, referred to higher centre for slab application.”

Following this, the school informed his father who took his son to Chacha Nehru Bal Chikitsalaya where the staff informed them that no doctor was available. “We were told that no doctor was available as it was already 5.30 pm and doctors leave the hospital at 3 pm,” Kumar told TOI

Frustrated with the delay in treatment, his father approached a private hospital- Chandra Laxmi Hospital in Vaishali Sector 4. The doctors there plastered his fractured arm around 12.30 am.

“Instead of running to yet another govt hospital, we decided to go to a private one as my son was in a lot of pain for several hours,” Kumar said. 

The boy’s father who works as a security guard with a monthly salary of Rs 15,000 invested Rs 13000 at the private facility after borrowing the money from his father. 

The incident soon gained the attention of Health Minister Saurabh Bharadwaj after TOI published the article on April 4. Bharadwaj expressed his disappointment with his secretary, who allegedly gave him incorrect information about the condition of government hospitals in Delhi. He pointed out that the senior officials in the Health and Family Welfare Department appeared to be either unaware of the actual situation or deliberately ignoring the urgent problem.

He stated that he had repeatedly instructed the chief secretary and the health secretary to ensure that medications and supplies were available in all healthcare facilities under the Delhi government. Despite expecting prompt action from the officials, he accused them of intentionally deceiving him about the situation.

This comes after a meeting was held on March 15 about the availability of medicines and consumables where all MS/MDs were informed that all the essential medicines, consumables and testing facilities are available in the hospitals. 

Bharadwaj said, “The poorer and most impoverished categories of people in the society were dependent on the free services at these facilities because they couldn’t afford expensive private facilities. It is tragic that a child with a broken arm was turned away from two govt hospitals and the poor family had to cough up a prohibitive amount at a private hospital.”

“What is the use of a hospital if it doesn’t have something as basic as cotton? There may be many such incidents that may have occurred and have not been reported,” he added.

Ashok Agarwal who was the first to raise the issue took it to the District High Court on April 4. In a post on X, he wrote “Today I raised this issue in the DHC. Judges expressed displeasure on such non-stop happenings. Parents with the child were also present in the courtroom.”

Speaking to TOI, he said it was “painful that a small child has to suffer because of the system’s incompetence”.

Dr Ritesh Ranjan, casualty in charge at Hedgewar Hospital said Cotton was not available at the time when the boy reached the hospital seeking emergency treatment. However, TOI reported that he could not provide a reason and claimed that he did not look after purchases or stocks.

Meanwhile, the additional medical superintendent of Hedgewar Hospital Mirtunjay Kumar, said, “There was some miscommunication as cotton was available in a store but somehow did not reach the emergency ward.” 

On the other hand, Dr Seema Kapoor, director of Chacha Nehru Bal Chikitsalaya, said,”We have two orthopaedic consultants at the hospital, who are available from 9 am till 4 pm. We have paediatric super-speciality orthopaedic services but they are timebound and tailored. We have requested Delhi govt for additional staff.” The consultation time has now been extended to 8 pm on all working days.

Also Read: Denied discount on bill, Gurugram hospital staff thrashed by patient’s kin

Powered by WPeMatico

Dr Reddy’s Labs arm introduces AI, machine learning assisted drug discovery platform Aurigene.AI

Hyderabad: Aurigene Pharmaceutical Services Limited, a contract research, development, and manufacturing services organization and a Dr Reddy’s Laboratories company, introduces Aurigene.AI, an AI and ML-assisted platform for accelerating drug discovery projects from hit identification to candidate nomination.

Aurigene.AI combines advanced physics-based simulation, generative and predictive AI models, and CADD (Computer-Aided Drug Design) in one platform, allowing users to pick the appropriate algorithms for a given application. The modular platform also consists of a meticulously curated database of 180 million compounds and 1.6 million validated bioassay data points. This database is ever-expanding and serves as training data for the platform.

Aurigene.AI is hosted on Google Cloud, which offers a scalable infrastructure for handling large datasets and efficient computation while safeguarding client data confidentiality.

Integrating AI and ML-based solutions with Aurigene’s core capabilities in chemical design, synthesis, and assessment in bioassays will facilitate faster development of novel therapeutics. Discovery scientists at Aurigene have validated the platform using a case study and demonstrated that the application of Aurigene.AI reduced the cycle time from chemical design to synthesis and testing by 35%.

Akhil Ravi, CEO, Aurigene Pharmaceutical Services Ltd., said, “We are committed to continually advancing our service experience and providing innovative end-to-end solutions to our global partners. Aurigene.AI is an important addition to our small molecule discovery offering and represents a data-driven approach to novel therapeutic development.”

Dr. Gayathri Ramaswamy, Global Head of Discovery Services, Aurigene Pharmaceutical Services Ltd., said, “The addition of AI and iterative machine learning capabilities to our core expertise in synthesizing and testing molecules will significantly reduce the DMTA cycle time in the discovery process. Aurigene.AI augments our core scientific capabilities in the small molecule discovery space and will serve as an efficient engine towards identifying a drug candidate.”

Aurigene Pharmaceutical Services is a global contract research, development, and manufacturing organization (CRDMO). The Company offers integrated and standalone services for discovery chemistry, biotherapeutics discovery, discovery biology, development, and manufacturing services for clinical phase I-III programs, regulatory submission batches, and commercial manufacturing. What sets Aurigene apart is the integrated API and formulations service that spans from key starting material, advanced intermediates, and APIs to finished products such as oral solids, sterile products, nasal solutions, etc. GMP commercial manufacturing facilities in the UK, Mexico, US, and India complement its development and pharmaceutical API manufacturing services in India.

Read also: Dr Reddy’s Labs to promote, distribute Sanofi paediatric, adult vaccine brands in India

Powered by WPeMatico

Medical Bulletin 05/ April/ 2024

Here are the top medical news for the day:

Use of cannabis impacts breast milk and lactation, finds study
In a recent study published in the journal Advances in Nutrition, researchers explored the impact of cannabis use during pregnancy and lactation. More specifically, they examined the effects of cannabinoids on lipid metabolism in the breast tissue and hormone receptors that regulate breast milk secretion and production.
The prevalence of cannabis use has been reported to increase by over 62% among pregnant women. Fewer women of reproductive age believe that cannabis use is dangerous, with many considering it medicinal, more effective, and less toxic than many medications, prescription or otherwise, for morning sickness. Lactating women often cite conditions like anxiety, depression, nausea, loss of appetite, chronic pain, and posttraumatic stress disorder as reasons for their cannabis use. The fetus is exposed to maternally absorbed cannabis and its metabolites. Previous studies have shown a loss of verbal aptitude, attention, and short-term memory in fetuses exposed to cannabis in utero.
For the study, the researchers analysed pregnant women using cannabis and found that the use of cannabis among pregnant women doubled from 3.5% to 7% in 2017 and 2002, respectively, with the highest use reported during the first trimester. About 4% of breastfeeding women were currently using cannabis.
Cannabinoids initially boost prolactin secretion through CB1R activation in the brain’s pituitary gland, but later reduce levels via dopamine release. While rat studies show THC decreasing prolactin levels post-lactation, human research remains conflicting, with some suggesting reduced milk production and shorter breastfeeding in regular cannabis users. Endocannabinoids may prolong the time between suckling and oxytocin release, hindering milk ejection during breastfeeding.
The study concluded that cannabis use leads to the presence of cannabinoids in human milk, which may contribute to their long-term accumulation and inhibit milk production. It’s use may also alter breast milk composition through its effects on lipid metabolism. However, substantial research is needed utilising rigorous methods for milk collection and production to demonstrate any of these potential effects.
Reference: Castro-Navarre, I., Williams, J. E., Holdsworth, E. A., et al. (2024). Maternal cannabis use during lactation and potential effects on human milk composition and production: a narrative review. Advances in Nutrition. doi:10.1016/j.advnut.2024.100196.
Does good diet help prevent the development of dementia as people age?
A new study published in the Gerontological Society of America, explored nutritional choices that have been shown to improve cognition and decrease the risk of cognitive impairment and dementia in older adults.
Consumption of a healthful diet is a behavioural strategy that can help to prevent the development of dementia as people age, the publication stated. It also reports on the roles of vitamins and minerals in nutrition and brain function and focuses on how to implement person-centred conversations about the impact of diet and nutrition on overall wellness, including brain health.
The study discovered that the Mediterranean-DASH Diet Intervention for Neurodegenerative Delay (MIND diet) is linked with enhanced cognition. This dietary pattern emphasizes vegetables (especially green leafy ones), nuts, berries, beans, whole grains, fish, poultry, and extra virgin olive oil, while restricting red meat, processed meats, butter, regular cheese, pastries and sweets, and fried foods. Those following this diet were found to have cognitive abilities equivalent to being 7.5 years younger as it helps promotes better cognitive function through its emphasis on foods that are rich in nutrients known to support brain health.
“Using a person-centred approach that ties conversations about nutrition to patient goals is an effective strategy for starting conversations about diet and health,” said Kathryn Porter Starr, PhD, RDN from Duke University School of Medicine and Durham VA Medical Center.
Ideally, individuals are able to obtain all necessary nutrients from the MIND diet. However, the risk for inadequate vitamin and mineral intake increases as people age, and some people may benefit from consumption of fortified foods and or dietary supplements to enhance their nutritional status.
“I would love for everybody to get all of their micronutrients from food. Unfortunately, for most older adults, it’s really challenging to do that due to physiological changes that occur with ageing and certain disease states that affect absorption, so we often recommend a multivitamin.” said Starr.
Reference: “Insights & Implications in Gerontology: The Vital Role of Nutrition in Brain Health,”; The Gerontological Society of America
Migraine and susceptibility to blood clots can heighten the risk of stroke, finds study
A study published in the journal Circulation: Cardiovascular Quality and Outcomes examined how non-traditional and traditional risk factors for stroke contributed to stroke in younger adults.
Stroke prevention is a crucial area of preventative health measures. Because of the dangers of strokes, people must know if they are at risk and what they may be able to do to modify their risk. While younger individuals typically have a lower stroke risk, it is still important to note what risk factors affect younger populations, particularly as the consequences of a stroke can be lifelong. Traditional risk factors for stroke include high blood pressure, diabetes, high cholesterol, and obesity while non-traditional include pregnancy and postpartum period, use of oral contraceptives, migraine, and thrombophilia, which increases the risk of blood clots.
The case-control study identified index stroke events in young adults (aged 18–55 years), matched 1:3 to stroke-free controls, by sex, age, and pre-stroke period. All traditional and nontraditional risk factors were identified from enrolment until a stroke or proxy-stroke date (defined as the pre-stroke period). Conditional logistic regression models stratified by sex and age group first assessed the association of stroke with counts of risk factors.
The results showed that each traditional and nontraditional risk factors were associated with an increased risk of stroke in all sex and age groups. In adults aged 18 to 34 years, more strokes were associated with nontraditional than traditional risk factors. The contribution of nontraditional risk factors declined with age. Hypertension was the most important traditional risk factor and increased in contribution with age. Migraine was the most important nontraditional risk factor and decreased in contribution with age.
The findings revealed that non-traditional risk factors were as important as traditional risk factors in the development of strokes for both young men and women and have a stronger association with the development of strokes in adults younger than 35 years of age.
Reference: Michelle H. Leppert, Sharon N. Poisson, Sharon Scarbro, Krithika Suresh, Lynda D. Lisabeth, Jukka Putaala, Lee H. Schwamm, Stacie L. Daugherty, Cathy J. Bradley, James F. Burke and P. Michael Ho; Association of Traditional and Nontraditional Risk Factors in the Development of Strokes Among Young Adults by Sex and Age Group: A Retrospective Case-Control Study; Journal: Circulation: Cardiovascular Quality and Outcomes; https://doi.org/10.1161/CIRCOUTCOMES.123.010307

Powered by WPeMatico

54 medicines will see only 1 paisa hike: Health Ministry after media reports on drug price hike

New Delhi: Responding to several media reports about the price rise of essential medicines from April 1, 2024, the Ministry of Health and Family Welfare has come out with a statement calling many reports claiming medicine prices to witness a significant hike by up to 12% from April, 2024 as false, misleading and malicious.

The ministry has clarified that of the 923 formulations which fall under the ceiling price, 728 will see no change in prices while 54 will see a price rise of merely one paisa.

“Some media reports have highlighted that medicine prices will witness a significant hike by up to 12% from April, 2024. These reports further claim that more than 500 medicines will be affected by this increase in price. Such reports are false, misleading and malicious,” the Ministry informed. 

As per the provisions of Drug Price Control Orders (DPCO) 2013, drugs are categorized as scheduled and non-scheduled formulations. The formulations which are listed in Schedule-I of DPCO 2013 are scheduled formulations and the formulations that are not specified in Schedule-I of DPCO 2013 are non-schedule formulations. National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals annually revises the ceiling prices of scheduled medicines on the basis of Wholesale Price Index (WPI). The scheduled medicines included in the Schedule-I of the DPCO, 2013 are essential medicines.

“During the calendar year 2023 over the corresponding period in 2022, the annual change in WPI with base year 2011-12 was (+) 0.00551% as per data published by Department for Promotion of Industry and Internal Trade (DPIIT). Accordingly, the Authority in its meeting held on 20.03.2024 has approved the WPI increase @ (+) 0.00551% for the scheduled medicines,” Health Ministry stated.

“The ceiling prices on 923 medicines are effective as on date. Based on the above mentioned WPI factor of (+) 0.00551%, there will be no change in the prevailing ceiling prices for 782 medicines and the existing ceiling prices will continue to prevail up to 31.03.2025. Fifty-Four (54) medicines with ceiling price ranging from Rs. 90 to Rs. 261 will have a miniscule increase of Rs. 0.01(one paisa). As the permissible price increase is miniscule, the companies may or may not avail this increase. Thus, in the year FY 2024-25, there will be almost no change in the ceiling price of medicines based on WPI,” it noted.

“The WPI increase is the maximum increase permissible as per the DPCO, 2013 and the manufacturers may or may not avail this increase, keeping in view the market dynamics. The companies adjust their Maximum Retail Price (MRP) depending upon the ceiling price of their medicines, as MRP (excluding GST) can be any price which is less than the ceiling price. The revised prices will be applicable from 1st April 2024 and the detail of revised prices is available on NPPA’s website,” it added.

In case of non-scheduled formulation, a manufacturer is at liberty to fix the price. However, no manufacturer of non-scheduled formulation can increase the MRP by more than 10% during preceding 12 months under Para 20 of DPCO, 2013.

Powered by WPeMatico

Biological mechanism discovered that could lead to new treatments for neurological disorders and cancers

The lab of Yongchao C. Ma, Ph.D., at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago has discovered a fundamental biological mechanism that could lead to new treatments for neurological diseases, such as spinal muscular atrophy (SMA) and autism, as well as different cancers.

Powered by WPeMatico

Study finds many younger people from high income neighborhoods jumped the eligibility queue for COVID-19 vaccines in NYC

Despite vaccine shortages, many younger people in New York City accessed vaccines ahead of schedule, particularly in high-income areas, according to new research at Columbia University Mailman School of Public Health.

Powered by WPeMatico